Full-Time

Sr Data Engineer

Posted on 5/15/2025

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

Category
Data Engineering
Data & Analytics
Required Skills
Data Science
Git
Apache Spark
SQL
AWS
Jenkins
Maven
Databricks
Data Analysis
Requirements
  • Doctorate degree OR
  • Master’s degree and 4 to 6 years of Computer Science, IT or related field experience OR
  • Bachelor’s degree and 6 to 8 years of Computer Science, IT or related field experience OR
  • Diploma and 10 to 12 years of Computer Science, IT or related field experience
  • Hands on experience with big data technologies and platforms, such as Databricks, Apache Spark (PySpark, SparkSQL), workflow orchestration (Apache airflow), performance tuning on big data processing
  • Proficiency in data analysis tools (eg. SQL) and experience with data visualization tools
  • Excellent problem-solving skills and the ability to work with large, complex datasets
  • Strong understanding of data governance frameworks, tools, and best practices.
  • Knowledge of data protection regulations and compliance requirements (e.g., GDPR, CCPA)
  • Experienced with software engineering best-practices, including but not limited to version control (Git, Subversion, etc.), CI/CD (Jenkins, Maven etc.), automated unit testing, and Dev Ops
Responsibilities
  • Collaborate with Clinical Trial Management (CTM) Data Architects, Business SMEs, and Data Scientists to design and develop end-to-end data pipelines to meet fast paced business needs across geographic regions
  • Design, develop, and maintain data solutions for data generation, collection, and processing of various data sets from different source systems (like Vault Clinical, Vault RIM, Clinical Trial Data Foundation and other Amgen systems)
  • Be a key team member that assists in design and development of the data pipeline
  • Create data pipelines and ensure data quality by implementing ETL processes to migrate and deploy data across systems
  • Contribute to the design, development, and implementation of data pipelines, ETL/ELT processes, and data integration solutions
  • Take ownership of data pipeline projects from inception to deployment, manage scope, timelines, and risks
  • Collaborate with cross-functional teams to understand data requirements and design solutions that meet business needs
  • Develop and maintain data models, data dictionaries, and other documentation to ensure data accuracy and consistency
  • Implement data security and privacy measures to protect sensitive data
  • Leverage cloud platforms (AWS preferred) to build scalable and efficient data solutions
  • Collaborate and communicate effectively with product teams
  • Stay up to date with latest technology trends & adhere to best practices for coding, testing and designing reusable code/component
Desired Qualifications
  • Experience with ETL tools such as Apache Spark, and various Python packages related to data processing, machine learning model development
  • Strong understanding of data modeling, data warehousing, and data integration concepts
  • Knowledge of SageMaker, cloud data platforms
  • Familiarity with SQL/NOSQL database, vector database for large language models
  • AWS Certified Data Engineer (Preferred)
  • Databricks Certification (Preferred)
  • SAFE for Teams Certification (Preferred)

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's approach involves a strong commitment to research and development, allowing them to create new treatments and maintain a pipeline of potential therapies. Unlike many competitors, Amgen reinvests a significant portion of its earnings back into R&D, emphasizing its dedication to innovation and patient care. The goal of Amgen is to provide effective therapeutic solutions to patients worldwide.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.